Safety Related Changes 06 Jul 15
July 6, 2015
Eliquis (apixaban) is now
indicated for the treatment of
deep vein thrombosis (DVT) and
pulmonary embolism (PE) in adult
patients. It is now also
indicated for the prevention of
recurrent DVT and PE in adult
patients.
Exelon patch (rivastigmine) is
now indicated for the treatment
of patients with mild, moderate
and severe dementia of the
Alzheimer’s type.
Galvus (vildagliptin) is now
indicated as monotherapy in
patients inadequately controlled
by diet and exercise alone and for
whom metformin is inappropriate
due to contraindications or
intolerance.
Imojev (Japanese encephalitis
vaccine (live, attenuated)) is
now indicated for prophylaxis of
Japanese encephalitis caused by
the Japanese encephalitis virus, in
individuals from 9 months of age
and over.
Suboxone sublingual film
(buprenorphine hydrochloride
and naloxone hydrochloride)
is now contraindicated in severe
hepatic insufficiency (Child‑Pugh C).
Vivaxim (salmonella typhi Vi
polysaccharide and inactivated
hepatitis A virus antigen
(inactivated, adsorbed) vaccine)
should not be administered to
anyone with a history of severe
allergic reaction to any component
of the vaccine; or after previous
administration of the vaccine; or
to a vaccine containing the same
components or constituents.
Vaccination must be postponed in
case of febrile or acute disease.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jul 15To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jul 15
